Investigating how drugs behave in different animal models.
Official title: SRI 2023 RODENT AND NON-RODENT PHARMACOKINETIC STUDIES
Funded at Sri International · NIH-10949354 · Data updated 2026-11-12
This study is looking at how different medications move through the body in animals to help scientists create safer and more effective drugs for people like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | July 3, 2023 |
| Project end | July 2, 2026 |
| Funding year | 2023 |
| Award (this year) | $72,712 |
| NIH project number | 271201600006I-0-759502300001-1 |
| Project ID | NIH-10949354 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit would be individuals involved in clinical trials for new therapeutics.
✕Less likely to help
Patients with conditions that are not being targeted by the therapeutics studied may not receive any benefit.
What this research studies
This research focuses on understanding the pharmacokinetics of various therapeutics in both rodent and non-rodent models. By examining how these drugs are absorbed, distributed, metabolized, and excreted, the research aims to provide insights that could inform future drug development. Patients may benefit indirectly as findings could lead to safer and more effective medications. The approach involves detailed management and operational support for pharmacology and toxicology studies.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective drugs for patients.
How similar studies have gone: While pharmacokinetic studies are common, the specific focus on both rodent and non-rodent models may provide novel insights that have not been extensively explored.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Ho, Lynne — Sri International
- Study coordinator: Ho, Lynne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.